(Q73669697)
Statements
IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months (English)
S A Brod
L D Nelson
M Khan
scientific article published on 01 June 1997